OBJECTIVES: This study is aiming at 1) tracking expenditure on HIVAIDS, 2)how the government contributed to one of the MDG priority programs in Indonesia and its sustainability for future financing since Indonesia is one country with growring number of new HIVAIDS infections. METHODS: Cross sectional data from 2006-2012 was used to capture spending for HIVAIDS interventions, followed by policy discussion RESULTS: Total spending for HIVAIDS interventions increased from USD 56,5 miilion in 2006 to USD 87 million in 2012. The government contribution has slightly increased (26.6% in 2006 and 42.36% in 2012). We found that 75% in 2011 and 70% in 2012 of the spending were related to health. Government contribution for HIVAIDS as compared to total health expenditure was very limited, amounted to 0,29%, 0,27% and 0,26% in 2009, 2010 and 2011 respectively. In contrast, for priority programs such as HIVAIDS, external partner contribution has been substantial. There has been a discussion to integrate financing to the publicly funded program such as universal coverage that has just started recently.  Further analysis on Opportunitistic Infection and STDs service provision for most at risk population was done to assess potential inclusion to the benefit package.  Separation of the cost components to balance the role of the government and other sources was also assessed. Unit cost of the STDs treatment is USD 24 excluding equipment and drug. However,other country’s experience showing that the interventions are integrated in the universal coverage using different scheme or top-up.  CONCLUSIONS: It should be carefully assessed the integration of HIVAIDS  treatment to the universal coverage scheme. Stigma reduction and different price for private clinics need to be  explored to support quality and equity. To ensure sustainability of the program government should play a central role to maintain the program, involving NGOs to engage MARP and PLHIV.